Important Group Differences on the Functional Assessment of Cancer Therapy –Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

This study aimed to estimate important difference (ID) in FKSI DRS scores that is considered to be meaningful when comparing treatment effect between groups , using mRCC trial data.

Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: D Cella, R Motzer, BI Rini, JC Cappelleri, K Ramaswamy, B Arondekar, AG Bushmakin Source Type: research